At the AstraZeneca DISC in Cambridge UK, more than 2,000 scientists work in drug discovery and development, across therapy areas, each playing a central role in the mission to deliver life-changing medicines to patients. 

The British Pharmacological Society is a charity whose mission is to promote and advance pharmacology in all its forms.

Metrion is a CRO specialising in ion channel screening, cardiac safety and neuroscience assays. We deliver high-quality data, expert analysis and collaborative support as an extension of your research team.

Domainex is a multi‑award‑winning, integrated drug discovery CRO providing tailored services from target expression through to the identification of pre‑clinical candidates.

Its multidisciplinary capabilities span medicinal and synthetic chemistry, computational chemistry, protein production, assay development, high‑throughput and fragment screening, virtual screening, structural biology, ADMET profiling, and bioanalysis, supporting a broad set of modalities, targets and therapeutic areas.

Nanion Technologies is a renowned global provider of high-performance electrophysiology instrumentation for life sciences. We specialize in three core areas: automated patch clamp, membrane biophysics, and cell analytics instruments. Our automated patch clamp and membrane biophysics instruments are used in all stages of drug discovery, from hit discovery through lead optimization to safety pharmacology, and can also be used for complex biophysical analysis of ion channels in academic research. Our cell analytics instruments offer real-time, label-free cellular monitoring, streamlining toxicology and drug efficacy assessments. By combining trusted scientific support with exceptional instrumentation we help researchers accelerating successful drug development and scientific discoveries.

Sophion Bioscience specialises in developing and manufacturing automated, cutting­edge technology for pre-clinical life sciences. Building on our legacy of pioneering automated patch clamping for ion channel research, our solutions empower the study of drug candidates, therapeutics, and precision medicine at the bench, saving billions before clinical trials. We collaborate with scientists to accelerate the discovery and development of safer, more effective drugs. By partnering with academic institutions, contract research organisations (CROs), cell line providers, and leading pharmaceutical companies, we develop assays for screening and characterisation. Together, we are leading the way in automated technologies for biology, facilitating efficient drug discovery and ensuring the highest standards of patient safety in the development of new drugs.

We are headquartered in Denmark and have subsidiaries in the United States, Japan and, China.